Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akebia Therapeutics Inc. buy HC Wainwright

Akebia Therapeutics Inc.
Start price
€1.82
28.03.24 / 50%
Target price
€5.55
28.03.25
Performance (%)
-31.58%
Price
€1.25
26.04.24
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright for Akebia Therapeutics Inc. is performing very badly with a performance of -31.58%. This prediction currently runs until 28.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this prediction
Performance without dividends (%)
Name 1w
Akebia Therapeutics Inc. -1.887%
iShares Core DAX® 2.594%
iShares Nasdaq 100 3.553%
iShares Nikkei 225® 0.687%
iShares S&P 500 2.209%

Comments by HC_Wainwright for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -31.58%
Target price 5.552
Change
Ends at 28.03.25

Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at HC Wainwright from $5.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat

HC Wainwright 
0
Report Share
28.03.24

Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
17.11.23
€4.60
17.11.24
33.26%
26.04.24

HC Wainwright 
17.11.23 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.11
27.09.23
€3.55
27.09.24
12.23%
26.04.24

HC Wainwright 
27.09.23 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
28.08.23
€3.47
28.08.24
-1.73%
26.04.24

HC Wainwright 
28.08.23 50%